Cancer and the FRA3B/FHIT fragile locus: it's a HIT
Open Access
- 13 May 2003
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (10) , 1501-1506
- https://doi.org/10.1038/sj.bjc.6600937
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Multiple molecular alterations of FHIT in betel‐associated oral carcinomaThe Journal of Pathology, 2002
- FRA3B and other common fragile sites: the weakest linksNature Reviews Cancer, 2001
- Altered Expression of the Fragile Histidine Triad Gene in Primary Gastric AdenocarcinomasBiochemical and Biophysical Research Communications, 2001
- FHIT gene therapy prevents tumor development in Fhit-deficient miceProceedings of the National Academy of Sciences, 2001
- Analysis of Intratumoral Heterogeneity of Chromosome 3p Deletions and Genetic Evidence of Polyclonal Origin of Cervical Squamous CarcinomaLaboratory Investigation, 2001
- Frequent Altered Expression of Fragile Histidine Triad Protein in Human Colorectal AdenomasBiochemical and Biophysical Research Communications, 2000
- Muir–Torre-like syndrome in Fhit-deficient miceProceedings of the National Academy of Sciences, 2000
- Clinicopathologic Features andFHITGene Expression in Sporadic Colorectal AdenocarcinomasScandinavian Journal of Gastroenterology, 2000
- THE ROLE OF THE FHIT/FRA3B LOCUS IN CANCERAnnual Review of Genetics, 1998
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996